FDCDDQ
INSY

Federation des caisses Desjardins du Quebec’s Insys Therapeutics, Inc. INSY Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-120
Closed -$554 – 2370
2019
Q1 		$554 Hold
120
– – ﹤0.01% 2006
2018
Q4 		$420 Hold
120
– – ﹤0.01% 2011
2018
Q3 		$1.21K Hold
120
– – ﹤0.01% 2028
2018
Q2 		$869 Hold
120
– – ﹤0.01% 2079
2018
Q1 		$725 Sell
120
-440
-79% -$3.63K ﹤0.01% 2071
2017
Q4 		$5.39K Sell
560
-5,000
-90% -$32.7K ﹤0.01% 1856
2017
Q3 		$49.4K Buy
5,560
+5,000
+893% +$51.6K ﹤0.01% 1316
2017
Q2 		$7.08K Buy
+560
New +$6.63K ﹤0.01% 1822

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's INSY Position: Q2 2019 in Review

Federation des caisses Desjardins du Quebec sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 120 shares — an estimated $554 sold.

Federation des caisses Desjardins du Quebec first reported a position in INSY in Q2 2017 and held it in 8 quarters. The position peaked at $49.4K in Q3 2017. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Federation des caisses Desjardins du Quebec reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 120 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $554.
  • Federation des caisses Desjardins du Quebec first reported a position in Insys Therapeutics, Inc. in Q2 2017 and held it in 8 quarters.
  • Federation des caisses Desjardins du Quebec's Insys Therapeutics, Inc. position peaked at $49.4K in Q3 2017.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2019, filed 30 Aug 2024.